1AD Share Price History
19 Oct, 2019
Every investor in AdAlta Limited (ASX:1AD) should be aware of the most powerful shareholder groups. Insiders often own...
09 Oct, 2019
MELBOURNE, Australia, Oct. 9, 2019 /PRNewswire/ -- The Board of AdAlta Limited (1AD.AX), is pleased to announce the appointment of experienced global pharmaceutical executive Dr Tim Oldham as Chief Executive Officer and Managing Director. Dr Oldham has extensive skills and expertise over his career in the industry in strategy and portfolio building, biologic therapies development and pipeline commercialisation.
16 Sep, 2019
AdAlta secures licensing deal for the i-body platform with global medical technology and diagnostics firm, GE Healthcare
AdAlta secures commercial agreement for its i-body platform with global medical technology and diagnostics firm, GE Healthcare. Under the licensing deal, the two companies will develop i-bodies for diagnostic imaging. AdAlta will screen its novel i-body library on a number of targets in order to identify i-bodies that GE can use as imaging agents, starting with Granzyme B.
05 Sep, 2019
Even the best stock pickers will make plenty of bad investments. Unfortunately, shareholders of AdAlta Limited...